In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Parenterals has informed that the Board of Directors of the Company in its meeting held on today 05th June, 2021, has considered and approved the following: Audited Financial Result (Standalone and Consolidated) for the year ended on 31st March, 2021, along with Auditor's Report thereon with Unmodified Opinion. In this respect, it has enclosed following: Audited Financial Results (Standalone and Consolidated) for the year ended on 31st March, 2021, Auditor's Report on the said financial results and declaration by the company as to the Unmodified Opinion expressed by the Statutory Auditors on Audited Financial Results (Standalone and Consolidated). The meeting of Board of Directors commenced at 13.00 pm and concluded at 14.05 pm.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: